p53 codon 72 polymorphism and the risk of esophageal cancer: A Korean case-control study

Diseases of the Esophagus

Volumn 24, Issue 8, 2011, Pages 596-600

  Piao, J M ^a,c   Kim, H N ^b   Song, H R ^a   Kweon, S S ^a,b   Choi, J S ^a   Yoon, J Y ^a   Chung, I J ^a   Kim, S H ^a   Shin, M H ^a  

^a Chonnam National University Medical School   (South Korea)

^b Chonnam National University Research Institute of Medical Sciences   (South Korea)

^c YANBIAN UNIVERSITY   (China)

Author keywords

Esophageal cancer; p53 codon 72 polymorphism; South Korea

Indexed keywords

ARGININE; PROLINE; PROTEIN P53;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CANCER STAGING; CASE CONTROL STUDY; CODON; CONTROLLED STUDY; DRINKING BEHAVIOR; ESOPHAGUS CANCER; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SOUTH KOREA;

ADULT; AGED; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; GENES, P53; GENOTYPE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; REPUBLIC OF KOREA; RISK FACTORS; SMOKING;

EID: 80855131548     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2011.01203.x     Document Type: Article

References (29)

1. Ferlay J, Shin H R, Bray F, Forman D, Mathers C, Parkin D M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-917.
2. Jung K W, Park S, Kong H J etal. Cancer statistics in Korea: incidence, mortality and survival in 2006-2007. J Korean Med Sci 2010; 25: 1113-21.
3. Enzinger P C, Mayer R J. Esophageal cancer. N Engl J Med 2003; 349: 2241-52.
4. Cao B, Tian X, Li Y etal. LMP7/TAP2 gene polymorphisms and HPV infection in esophageal carcinoma patients from a high incidence area in China. Carcinogenesis 2005; 26: 1280-4.
5. Shao Y, Tan W, Zhang S. P53 gene codon 72 polymorphism and risk of esophageal squamous cell carcinoma: a case/control study in a Chinese population. Dis Esophagus 2008; 21: 139-43.
6. Sepehr A, Taniere P, Martel-Planche G etal. Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran. Oncogene 2001; 20: 7368-74.
7. Hernandez-Boussard T, Rodriguez-Tome P, Montesano R, Hainaut P. IARC p53 mutation database: a relational database to compile and analyze p53 mutations in human tumors and cell lines. International Agency for Research on Cancer. Hum Mutat 1999; 14: 1-8.
8. Biramijamal F, Allameh A, Mirbod P, Groene H J, Koomagi R, Hollstein M. Unusual profile and high prevalence of p53 mutations in esophageal squamous cell carcinomas from northern Iran. Cancer Res 2001; 61: 3119-23.
9. Vogelstein B, Lane D, Levine A J. Surfing the p53 network. Nature 2000; 408: 307-10.
10. Harris S L, Levine A J. The p53 pathway: positive and negative feedback loops. Oncogene 2005; 24: 2899-908.
11. Fan R, Wu M T, Miller D etal. The p53 codon 72 polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2000; 9: 1037-42.
12. Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 1999; 19: 1092-100.
13. Soulitzis N, Sourvinos G, Dokianakis D N, Spandidos D A. p53 codon 72 polymorphism and its association with bladder cancer. Cancer Lett 2002; 179: 175-83.
14. Papadakis E N, Dokianakis D N, Spandidos D A. p53 codon 72 polymorphism as a risk factor in the development of breast cancer. Mol Cell Biol Res Commun 2000; 3: 389-92.
15. Perez-Perez G I, Bosques-Padilla F J, Crosatti M L, Tijerina-Menchaca R, Garza-Gonzalez E. Role of p53 codon 72 polymorphism in the risk of development of distal gastric cancer. Scand J Gastroenterol 2005; 40: 56-60.
16. Fernandez-Rubio A, Lopez-Cima M F, Gonzalez-Arriaga P etal. The TP53 Arg72Pro polymorphism and lung cancer risk in a population of Northern Spain. Lung Cancer 2008; 61: 309-16.
17. Granja F, Morari J, Morari E C, Correa L A, Assumpcao L V, Ward L S. Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer. Cancer Lett 2004; 210: 151-7.
18. Piao J M, Kim H N, Song H R etal. p53 codon 72 polymorphism and the risk of lung cancer in a Korean population. Lung Cancer 2011 doi:10.1016/j.lungcan.2010.12.017.
19. Song H-R, Kweon S-S, Kim H N, Piao J-M, Yun W-J, Choi J-S. p53 codon 72 polymorphism in patients with gastric and colorectal cancer in a Korean population. Gastric Cancer 2011. DOI: 10.1007/s10120-011-0034-4.
20. Lee J M, Lee Y C, Yang S Y etal. Genetic polymorphisms of p53 and GSTP1, but not NAT2, are associated with susceptibility to squamous-cell carcinoma of the esophagus. Int J Cancer 2000; 89: 458-64.
21. Hong Y, Miao X, Zhang X etal. The role of P53 and MDM2 polymorphisms in the risk of esophageal squamous cell carcinoma. Cancer Res 2005; 65: 9582-7.
22. Cai L, Mu L N, Lu H etal. Dietary selenium intake and genetic polymorphisms of the GSTP1 and p53 genes on the risk of esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2006; 15: 294-300.
23. Peixoto Guimaraes D, Hsin Lu S, Snijders P etal. Absence of association between HPV DNA, TP53 codon 72 polymorphism, and risk of oesophageal cancer in a high-risk area of China. Cancer Lett 2001; 162: 231-5.
24. Yang W, Zhang Y, Tian X, Ning T, Ke Y. p53 Codon 72 polymorphism and the risk of esophageal squamous cell carcinoma. Mol Carcinog 2008; 47: 100-4.
25. Canova C, Hashibe M, Simonato L etal. Genetic associations of 115 polymorphisms with cancers of the upper aerodigestive tract across 10 European countries: the ARCAGE project. Cancer Res 2009; 69: 2956-65.
26. Sobin L H, Wittekind C. TNM Classification of Malignant Tumors, 6th edn. New York: Wiley-Liss, 2002.
27. Kim H N, Lee I K, Kim Y K etal. Association between folate-metabolizing pathway polymorphism and non-Hodgkin lymphoma. Br J Haematol 2008; 140: 287-94.
28. Zhao Y, Wang F, Shan S etal. Genetic polymorphism of p53, but not GSTP1, is association with susceptibility to esophageal cancer risk - a meta-analysis. Int J Med Sci 2010; 7: 300-8.
29. Pim D, Banks L. p53 polymorphic variants at codon 72 exert different effects on cell cycle progression. Int J Cancer 2004; 108: 196-9.